Novozymes

  • Novozymes Biopharma wins technology innovation award

    Novozymes Biopharma has received the 2012 Drug Delivery Partnerships (DDP) Technology Innovation award for the company’s half-life extension platform. The award recognizes the most exciting delivery technology of the year.

    Novozymes | 08 February 2012

  • SAFC and Novozymes extend joint agreement

    SAFC , a member of the Sigma-Aldrich Group and Novozymes Biopharma agreed on a 10-year extension of their joint agreement under which SAFC retains exclusive marketing and distribution rights for Novozymes Biopharma’s LONGR³IGF-I (LONGR3) growth f…

    Novozymes | 05 October 2010

  • Novozymes and Prometic Team Up For Purification Of Proteins

    Novozymes and ProMetic Life Sciences have entered into a strategic alliance regarding proprietary albumin purification technology that is based upon a synthetic-ligand affinity adsorbent developed by the latter’s UK subsidiary, ProMetic BioSciences…

    Novozymes | 04 February 2010

  • Novozymes Biopharma Unveils Website

    Novozymes Biopharma has unveiled its website that has been designed to enhance usability and provide a comprehensive resource for information on products and technologies. The website provides visitors with quick and easy access to a wealth of in…

    Novozymes | 20 August 2009

  • NovozymesBiopharma and Millipore Launch Animal-Free Product

    Novozymes Biopharma and Millipore have launched the first product from their alliance to supply animal-free cell culture supplements for bioprocessing. CellPrime rTransferrin AF is an alternative to serum-derived human or bovine transferrin for i…

    Novozymes | 13 April 2009

  • New development in animal-free cell culture supplements

    Novozymes Biopharma announces a new development in animal-free supplements for industrial cell culture at BioProcess International Conference and Exhibition to be held from 23 to 26 September in California. The company will unveil the first produ…

    Novozymes | 22 September 2008

  • Novozymes Sees 15% Sales Growth

    Novozymes’ sales rose by 15% in local currencies in the first nine months of 2007. Measured in DKK sales rose by 11% to DKK 5,594 million (US$1,080.33 million) from DKK 5,038 million in 2006. Growth in local currencies excluding acquisitions was 12…

    Novozymes | 30 October 2007

  • Novozymes Builds In India

    Novozymes has decided to build new laboratory and office facilities in Bangalore, India, establishing R&D operations in India for the first time. The new buildings are expected to be completed mid-2008 and will provide office and laboratory space for…

    Novozymes | 09 March 2007